Hyperplexing: A Method for Higher-Order Multiplexed Quantitative Proteomics Provides a Map of the Dynamic Response to Rapamycin in Yeast
暂无分享,去创建一个
[1] E. O’Shea,et al. Global analysis of protein expression in yeast , 2003, Nature.
[2] Edward L Huttlin,et al. Correct Interpretation of Comprehensive Phosphorylation Dynamics Requires Normalization by Protein Expression Changes* , 2011, Molecular & Cellular Proteomics.
[3] E. Dubois,et al. Identification of direct and indirect targets of the Gln3 and Gat1 activators by transcriptional profiling in response to nitrogen availability in the short and long term. , 2006, FEMS yeast research.
[4] S. Gygi,et al. ms3 eliminates ratio distortion in isobaric multiplexed quantitative , 2011 .
[5] M. Mann,et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast , 2008, Nature.
[6] Juergen Kast,et al. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies , 2010, Expert Reviews in Molecular Medicine.
[7] Steven P Gygi,et al. The impact of peptide abundance and dynamic range on stable-isotope-based quantitative proteomic analyses. , 2008, Journal of proteome research.
[8] S. Schreiber,et al. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. von der Haar,et al. Optimized Protein Extraction for Quantitative Proteomics of Yeasts , 2007, PloS one.
[10] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[11] M. Mann,et al. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.
[12] M. Mann,et al. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics , 2004, Nature Biotechnology.
[13] S. Haggarty,et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] Steven P Gygi,et al. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.
[15] Norman Pavelka,et al. Delayed Correlation of mRNA and Protein Expression in Rapamycin-treated Cells and a Role for Ggc1 in Cellular Sensitivity to Rapamycin* , 2009, Molecular & Cellular Proteomics.
[16] W. Liang,et al. 9) TM4 Microarray Software Suite , 2006 .
[17] Maitreya J. Dunham,et al. Identification of Aneuploidy-Tolerating Mutations , 2010, Cell.
[18] John N. Weinstein,et al. High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID) , 2005, BMC Bioinformatics.
[19] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[20] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[21] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[22] Steven P Gygi,et al. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry , 2008, Nature Protocols.
[23] Ron Shamir,et al. Clustering Gene Expression Patterns , 1999, J. Comput. Biol..
[24] Edward L. Huttlin,et al. A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression , 2010, Cell.
[25] T. Pan,et al. Integration of General Amino Acid Control and Target of Rapamycin (TOR) Regulatory Pathways in Nitrogen Assimilation in Yeast* , 2010, The Journal of Biological Chemistry.